Fibroblasts and the Forefront of Regenerative Medicine w/ Fibrobiologics CEO, Pete O'Heeron | HealthBiz Briefs

Send us a text Are stem-cell treatments the future of self-therapy and regenerative medicine? Or is there something better? In the latest episode of HealthBiz Briefs, host, David Williams, is joined by Pete O’Heeron, CEO of Fibrobiologics, explores the untapped potential of fibroblasts and their promise as a potentially superior and more affordable alternative to traditional stem-cell treatments. 🎙️⚕️ABOUT CARETALK CareTalk is a weekly podcast that provides an incisive, no B.S. view of the U...